Biological Research Laboratory at Indiana University Receives Waters Center of Innovation Honors
News Dec 13, 2012
At a ceremony at Indiana University’s Bloomington campus, Waters Corporation welcomed the Laboratory of Biological Mass Spectrometry and Professor David Clemmer, the Robert and Marjorie Mann Chair of Chemistry and the Associate Dean of Sciences in the College of Arts and Sciences into its Centers of Innovation Program. Waters honored Professor Clemmer’s contributions to ion mobility mass spectrometry that have given researchers everywhere new routes to discovery in the areas of protein characterization and the emerging field of proteomics.
Said Lauren Robel, Indiana University Provost and Executive Vice President, “On behalf of IU I am honored to welcome the Waters Corporation as our partner in our academic research mission, and to offer my personal congratulations to Professor Clemmer and his research team on earning this exceptional designation. This is an exciting collaboration and epitomizes the groundbreaking possibilities that emerge when leading university researchers team with pioneering private sector partners. The resulting innovations can revolutionize the ways in which we conduct research, greatly accelerate scientific discoveries and present students with unprecedented and remarkable opportunities to learn from and contribute to leading edge laboratory technologies.”
“This is a really important milestone in the life of our department and university. It’s an enormous honor for me to stand here before you to recognize one of our very best,” said Professor David Giedroc, Chair of the Department of Chemistry. “David has had a tremendous influence on the development of ion mobility mass spectrometry.”
In his remarks to the audience, John Gebler, General Manager of the Waters Centers of Innovation Program said, “It’s remarkable to see how far mass spectrometry has come over the last two decades. Today we honor a key contributor to the revolutionary developments that have taken place. When you see David’s laboratory, you can see the future of mass spectrometry taking shape with a passion and enthusiasm that is hard to find anywhere else.”
In acknowledging the honor, Professor Clemmer who, in 2009, received the Tracy M. Sonneborn Award, IU’s highest honor for excellence in research and teaching, was quick to credit others who have influenced his career. “This recognition from Waters Corporation means a lot to me. However, I have been very fortunate along the way to have been helped by many gifted students, colleagues, advisers and mentors and administrators who have put their faith in me. I cannot thank them enough for their contributions to my work in ion mobility mass spectrometry.”
In conjunction with the Centers of Innovation ceremony, Indiana University hosted a special half-day scientific Symposium in Professor Clemmer’s honor on Advancements in High Resolution Mass Spectrometry for Biomolecular Characterization. The Symposium featured leading international researchers in the field of ion mobility mass spectrometry including Prof. Perdita Barran, University of Edinburgh, Edinburgh, Scotland; Prof. Michael Gross, Washington, University, St. Louis, MO; Prof. Michael Przybylski, University of Konstanz, Konstanz, Germany; and Dr. Kevin Giles of Waters Corporation.
Bacterial Control Mechanism for Adjusting to Changing ConditionsNews
A fundamental prerequisite for life on earth is the ability of living organisms to adapt to changing environmental conditions. Physicists have now determined that the regulation mechanisms used by bacteria to adapt to different environments are based on a global control process that can be described in a single equation.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE